|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | |
| A61K 31/137 | |||
| A61K 31/4458 |
| (11) | Number of the document | 3272342 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17187023.1 |
| Date of filing the European patent application | 2012-03-23 | |
| (97) | Date of publication of the European application | 2018-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161466684 P | 2011-03-23 | US | |
| 201161561763 P | 2011-11-18 | US | |
| 201261591129 P | 2012-01-26 | US |
| (72) |
LICKRISH, David, KY
ZHANG, Feng, US
|
| (73) |
Ironshore Pharmaceuticals & Development, Inc.,
10 Market Street, Suite 715, Camana Bay 1-9006,
KY
|
| (54) | METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER |
| METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER |